Niels Kruse

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease.

Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease.

Journal: The journal of prevention of Alzheimer's disease

Published: January 08, 2026

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Journal: Science advances

Published: June 18, 2025

Synphilin-1 modulates alpha-synuclein assembly, release and uptake.

Synphilin-1 modulates alpha-synuclein assembly, release and uptake.

Journal: NPJ Parkinson's disease

Published: March 03, 2025

Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.

Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 11, 2024

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids.

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids.

Journal: Free neuropathology

Published: August 01, 2023

Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative study.

Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative study.

Journal: Journal of neurology

Published: September 19, 2022

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline.

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline.

Journal: Diagnostics (Basel, Switzerland)

Published: March 16, 2022

Anesthesia triggers drug delivery to experimental glioma in mice by hijacking caveolar transport.

Anesthesia triggers drug delivery to experimental glioma in mice by hijacking caveolar transport.

Journal: Neuro-oncology advances

Published: October 14, 2021

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 31, 2021

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.

Journal: Brain : a journal of neurology

Published: March 26, 2021

TREM2 expression in the brain and biological fluids in prion diseases.

TREM2 expression in the brain and biological fluids in prion diseases.

Journal: Acta neuropathologica

Published: February 23, 2021

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 23, 2020

Showing 1-12 of 39

Last Updated: 09/26/2026